ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "magnetic resonance imaging (MRI) and spondylarthritis"

  • Abstract Number: 2888 • 2013 ACR/ARHP Annual Meeting

    Frequent Detection Of Inflammation and Fat Infiltration Suggestive Of Spondyloarthritis On MRI Of The Entire Spine In Healthy Subjects and Patients With Mechanical Back Pain

    Ulrich Weber1, Zheng Zhao2, Veronika Zubler3, Stanley Chan4, Robert GW Lambert5, Mikkel Ostergaard6, Susanne Juhl Pedersen7, Kaspar Rufibach8 and Walter P. Maksymowych9, 1Rheumatology, Balgrist University Hospital, Zurich, Switzerland, 2Department of Rheumatology, University of Alberta and PLA General Hospital, Beijing, PR China, Beijing, AB, China, 3Radiology, Balgrist University Hospital, Zurich, Switzerland, 4Division of Ophthalmology, University of Alberta, Edmonton, AB, Canada, 5Radiology, University of Alberta, Edmonton, AB, Canada, 6Copenhagen Center for Arthritis Research, Glostrup, Denmark, 7Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, 8rePROstat, Basel, Switzerland, 9Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Mechanical back pain (MBP) patients and healthy subjects may show spinal MRI lesions suggestive for spondyloarthritis (SpA) such as corner inflammatory lesions (CIL) or…
  • Abstract Number: 2838 • 2013 ACR/ARHP Annual Meeting

    Relationship Between Active Inflammatory Lesions In The Spine and Sacroiliac Joints and Development Of Fatty Lesions On Whole-Body MRI In Patients With Early Axial Spondyloarthritis-  Long-Term Data Of The Esther Trial

    In-Ho Song1, Kay-Geert A. Hermann2, Hildrun Haibel3, Christian Althoff4, Denis Poddubnyy3, Joachim Listing5, Anja Weiss6, Ekkehard Lange7, Bruce Freundlich8, Martin Rudwaleit9 and Joachim Sieper10, 1Medical Department I, Rheumatology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany, 2Radiology, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 3Charité Universitätsmedizin Berlin, Berlin, Germany, 4Radiology, Charite Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 5German Rheumatism Research Center, Berlin, Germany, 6German Rheumatism Research Centre, Berlin, Germany, 7BU Specialty Care, Pfizer Pharma AG, Berlin, Germany, 8University of Pennsylvania, Philadelphia, PA, 9Endokrinologikum, Berlin, Germany, 10Medical Department I, Rheumatology, Charité Universitätsmedizin Berlin, Campus Benjamin-Franklin, Berlin, Germany

    Background/Purpose : In patients with early axial spondyloarthritis (SpA) with evidence of active inflammation on magnetic resonance imaging (MRI) in the spine and/or sacroiliac (SI-)joints…
  • Abstract Number: 2841 • 2013 ACR/ARHP Annual Meeting

    Inflammation and Structural Progression In The Sacroiliac Joints Of Patients With Axial Spa Treated With Adalimumab Or Placebo As Assessed By The Berlin and The Spondyloarthritis Research Consortium Of Canada MRI Methods

    Susanne Juhl Pedersen1, Denis Poddubnyy2, Inge Juul Sørensen3, Anne Gitte Loft4, Jens Skjødt Hindrup5, Gorm Thamsborg6, Karsten Asmussen7, Elka Kluger8, Jesper Nørregaard9, Torben Grube Christensen10, Anne G. Jurik11, J.M. Møller12, Thomas Skjødt13, Dorrit Mikkelsen14 and Mikkel Østergaard15, 1Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, 2Charité Universitätsmedizin Berlin, Berlin, Germany, 3Department of Rheumatology, Hvidovre Hospital, Copenhagen, Denmark, 4Department of Rheumatology, Sygehus Lillebaelt, Vejle, Denmark, 5Dep. of Rheumatology, Gentofte Hospital, Copenhagen, Denmark, 6Dep. of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 7Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, 8King Christian 10th Rheumatism Hospital at Gråsten, Graasten, Denmark, 9Dep of Rheumatology, Hørsholm Hospital, Hørsholm, Denmark, 10MD, Slagelse, Denmark, 11Department of Radiology, Aarhus University Hospital, Aarhus, Denmark, 12Department of Radiology, Copenhagen University Hospital in Herlev, Copenhagen, Denmark, 13Dep. of Radiology, Vejle Hospital, Vejle, Denmark, 14Dep. of Radiology, Aabenraa Hospital, Aabenraa, Denmark, 15Copenhagen University Hospital Glostrup, Copenhagen, Denmark

    Background/Purpose: To investigate changes in inflammation and structural progression in the sacroiliac joints (SIJs) in patients with axial spondyloarthritis (SpA) during treatment with adalimumab and…
  • Abstract Number: 1526 • 2013 ACR/ARHP Annual Meeting

    Stable Clinical and MRI Response In Patients With Early Axial Spondyloarthritis After 3 Years Of Continuous Treatment With Etanercept, Data Of The Esther Trial

    In-Ho Song1, Kay-Geert A. Hermann2, Hildrun Haibel1, Christian Althoff3, Denis Poddubnyy4, Joachim Listing5, Anja Weiss6, Ekkehard Lange7, Bruce Freundlich8, Martin Rudwaleit9 and Joachim Sieper4, 1Medical Department I, Rheumatology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany, 2Radiology, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 3Radiology, Charite Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 4Charité Universitätsmedizin Berlin, Berlin, Germany, 5German Rheumatism Research Center, Berlin, Germany, 6German Rheumatism Research Centre, Berlin, Germany, 7BU Specialty Care, Pfizer Pharma AG, Berlin, Germany, 8University of Pennsylvania, Philadelphia, PA, 9Endokrinologikum, Berlin, Germany

    Background/Purpose:     < style="text-align: justify;">In patients with early axial spondyloarthritis (SpA) with a disease duration of 10 years) where BASDAI50 response rates of 47%…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology